within Pharmacolibrary.Drugs.ATC.N;

model N03AF01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.8,
    Cl             = 0.0355,
    adminDuration  = 600,
    adminMass      = 0.4,
    adminCount     = 1,
    Vd             = 0.0008,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0016166666666666666,
    Tlag           = 19.8
  );

  annotation(Documentation(
    info ="<html><body><p>Carbamazepine is an anticonvulsant and mood-stabilizing drug primarily used for the treatment of epilepsy and neuropathic pain, as well as bipolar disorder. It is an approved medication used worldwide for controlling certain types of seizures, trigeminal neuralgia, and as an adjunct in the management of psychiatric disorders.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers following single oral dosing.</p><h4>References</h4><ol><li>T Tomson,Clinical pharmacokinetics of carbamazepine.,Cephalalgia : an international journal of headache,1987<a href='https://pubmed.ncbi.nlm.nih.gov/3322568/'>https://pubmed.ncbi.nlm.nih.gov/3322568/</a></li><li>L Bertilsson,Clinical pharmacokinetics of carbamazepine.,Clinical pharmacokinetics,1978<a href='https://pubmed.ncbi.nlm.nih.gov/346287/'>https://pubmed.ncbi.nlm.nih.gov/346287/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end N03AF01;
